GR
Glen Reid
University of Otago, The University of Sydney, University of Göttingen, University of Canterbury, Genesis Research and Development Corp Ltd
Research areas: Medicine · Pulmonary and Respiratory Medicine · Occupational and environmental lung diseases · MicroRNA in disease regulation · Cancer-related molecular mechanisms research
0000-0001-6465-5223
Employment
- 2018 - Present
- 2009 - 2018
-
Genesis Research and Development Corp Ltd2004 - 2009
- 2000 - 2003
Education
- 1997 - 2000
-
University of Canterbury BSc, MSc1991 - 1995
Projects & Funding
Projects & funding information is unavailable.
Publications (78)
- Epigenetic Profiling for Early Detection and Treatment Response Monitoring in Non–Small Cell Lung Cancer: Protocol for a Prospective Translational Biomarker Study Save
- YBX1 Expression Marks Proliferative Tumour States with Context-Dependent Genomic Instability: A Pan-Cancer Analysis Save
- Elevated YBX1 mRNA expression is associated with a genomically unstable and clinically aggressive cancer state: a pan-cancer analysis Save
- MicroRNA Mimics Based on the miR-15/107 Consensus Sequence Sensitise NSCLC Cells to Targeted Therapy Save
- MicroRNA Mimics Based on the miR-15/107 Consensus Sequence Sensitise NSCLC Cells to Targeted Therapy Save
- Therapeutic potential of synthetic microRNA mimics based on the miR-15/107 consensus sequence Save
- The Potential Links between lncRNAs and Drug Tolerance in Lung Adenocarcinoma Save
- Exploring MicroRNA and Exosome Involvement in Malignant Pleural Mesothelioma Drug Response Save
- Differential Expression of BARD1 Isoforms in Melanoma Save
- YB-1 Knockdown Inhibits the Proliferation of Mesothelioma Cells through Multiple Mechanisms Save
- High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes Save
- A link between the fibroblast growth factor axis and the miR-16 family reveals potential new treatment combinations in mesothelioma Save
- Biomarkers in malignant pleural mesothelioma: Current status and future directions Save
- Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma Save
- FGF2 and EGF induce epithelial-mesenchymal transition in malignant pleural mesothelioma cells via a MAPKinase/MMP1 signal Save
- Fundamentals of siRNA and miRNA therapeutics and a review of targeted nanoparticle delivery systems in breast cancer Save
- Response to "An innovative mesothelioma treatment based on mir-16 mimic loaded EGFR targeted minicells (TargomiRs)" Save
- Exploiting microRNAs As Cancer Therapeutics Save
- Posttranscriptional regulation controls calretinin expression in malignant pleural mesothelioma Save
- SFRP Tumour Suppressor Genes Are Potential Plasma-Based Epigenetic Biomarkers for Malignant Pleural Mesothelioma Save